Literature DB >> 8318485

Pathogenesis of acanthamoebic keratitis: hypothesis based on a histological analysis of 30 cases.

A Garner1.   

Abstract

The results of a histopathological study of 30 cases of Acanthamoeba keratitis are construed as indicating a four stage pathogenetic sequence: (1) initial infection, involving breaching of the surface epithelium; (2) keratocyte depletion by the invading trophozoites; (3) inflammatory response mediated by neutrophil polymorphonuclear leucocytes; (4) stromal necrosis attributable to leucocytic activity.

Entities:  

Mesh：

Year:  1993        PMID： 8318485      PMCID： PMC504533          DOI： 10.1136/bjo.77.6.366

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


  30 in total

1.  In vitro corneal pathogenicity of Acanthamoeba.

Authors:  D F Larkin; M Berry; D L Easty
Journal:  Eye (Lond)       Date:  1991       Impact factor: 3.775

2.  A comparison of the lesions produced in the cornea of the rabbit eye by microfilariae of the forest and Sudan-savanna strains of Onchocerca volvulus from Cameroon. II. The pathology.

Authors:  A Garner; B O Duke; J Anderson
Journal:  Z Tropenmed Parasitol       Date:  1973-12

3.  Immunity to pathogenic free-living amoebae.

Authors:  R T Cursons; T J Brown; E A Keys
Journal:  Lancet       Date:  1977-10-22       Impact factor: 79.321

4.  The diagnostic value of a ring infiltrate in acanthamoebic keratitis.

Authors:  F H Theodore; F A Jakobiec; K B Juechter; P Ma; R C Troutman; P M Pang; T Iwamoto
Journal:  Ophthalmology       Date:  1985-11       Impact factor: 12.079

Review 5.  Acanthamoeba, an opportunistic microorganism: a review.

Authors:  A J Martinez; K Janitschke
Journal:  Infection       Date:  1985 Nov-Dec       Impact factor: 3.553

6.  Activation of the alternative pathway of complement by Acanthamoeba culbertsoni.

Authors:  A Ferrante; B Rowan-Kelly
Journal:  Clin Exp Immunol       Date:  1983-11       Impact factor: 4.330

7.  Conditioned medium from stimulated mononuclear leukocytes augments human neutrophil-mediated killing of a virulent Acanthamoeba sp.

Authors:  A Ferrante; T J Abell
Journal:  Infect Immun       Date:  1986-02       Impact factor: 3.441

8.  Recovery of soil Amebas from the nasal passages of children during the dusty harmattan period in Zaria.

Authors:  R V Lawande; S N Abraham; I John; L J Egler
Journal:  Am J Clin Pathol       Date:  1979-02       Impact factor: 2.493

9.  Lectin receptors of rods and cones. Visualization by fluorescent label.

Authors:  C D Bridges
Journal:  Invest Ophthalmol Vis Sci       Date:  1981-01       Impact factor: 4.799

10.  Acquired immunodeficiency syndrome associated with Acanthamoeba infection and other opportunistic organisms.

Authors:  M M Gonzalez; E Gould; G Dickinson; A J Martinez; G Visvesvara; T J Cleary; G T Hensley
Journal:  Arch Pathol Lab Med       Date:  1986-08       Impact factor: 5.534
View more
  14 in total

1.  [The German Acanthamoeba keratitis register: Initial results of a multicenter study].

Authors:  L Daas; N Szentmáry; T Eppig; A Langenbucher; A Hasenfus; M Roth; M Saeger; B Nölle; B Lippmann; D Böhringer; T Reinhard; C Kelbsch; E Messmer; U Pleyer; S Roters; A Zhivov; K Engelmann; J Schrecker; L Zumhagen; H Thieme; R Darawsha; T Meyer-Ter-Vehn; B Dick; I Görsch; M Hermel; M Kohlhaas; B Seitz
Journal:  Ophthalmologe       Date:  2015-09       Impact factor: 1.059

2.  Therapeutic use of the 193-nm excimer laser in corneal pathologies.

Authors:  W Förster; U Atzler; I Ratkay; H Busse
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-05       Impact factor: 3.117

3.  Persistence of acanthamoeba antigen following acanthamoeba keratitis.

Authors:  Y F Yang; M Matheson; J K Dart; I A Cree
Journal:  Br J Ophthalmol       Date:  2001-03       Impact factor: 4.638

4.  Standardized method of measuring acanthamoeba antibodies in sera from healthy human subjects.

Authors:  C L Chappell; J A Wright; M Coletta; A L Newsome
Journal:  Clin Diagn Lab Immunol       Date:  2001-07

5.  Mannose induces the release of cytopathic factors from Acanthamoeba castellanii.

Authors:  H Leher; R Silvany; H Alizadeh; J Huang; J Y Niederkorn
Journal:  Infect Immun       Date:  1998-01       Impact factor: 3.441

6.  Failure of chemotherapy in the first reported cases of Acanthamoeba keratitis in Pakistan.

Authors:  Ruqaiyyah Siddiqui; Tanveer Chaudhry; Sahreena Lakhundi; Khabir Ahmad; Naveed Ahmed Khan
Journal:  Pathog Glob Health       Date:  2013-12-27       Impact factor: 2.894

Review 7.  Acanthamoeba spp. as agents of disease in humans.

Authors:  Francine Marciano-Cabral; Guy Cabral
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

8.  In vitro activity of Acanthamoeba castellanii on human platelets and erythrocytes.

Authors:  A Mattana; L Alberti; G Delogu; P L Fiori; P Cappuccinelli
Journal:  Infect Immun       Date:  2008-11-17       Impact factor: 3.441

9.  Induction of morphological and electrophysiological changes in hamster cornea after in vitro interaction with trophozoites of Acanthamoeba spp.

Authors:  Maritza Omaña-Molina; Fernando Navarro-García; Arturo González-Robles; José de Jesús Serrano-Luna; Rafael Campos-Rodríguez; Adolfo Martínez-Palomo; Víctor Tsutsumi; Mineko Shibayama
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

10.  The Antifungal Drug Isavuconazole Is both Amebicidal and Cysticidal against Acanthamoeba castellanii.

Authors:  Brian Shing; Seema Singh; Larissa M Podust; James H McKerrow; Anjan Debnath
Journal:  Antimicrob Agents Chemother       Date:  2020-04-21       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.